A study was considered to evaluate the correlation between IL-6 and clinical characteristics in GI cancer if a test was performed for cancer specific findings such as lymph node metastases, invasion, distant metastases or tumor size. This evidence concerns the gene IL6 and metastatic malignant neoplasm in the lymph nodes.